Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-05

Clinical Trial Update: Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Nucleo CMP Forte in pediatric traumatic brain injury; status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nucleo CMP Forte

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Brain Injuries | Phase 3 | Status: RECRUITING